The AQUARIUS study tested whether a drug called aliskiren could slow the progression of coronary artery disease (CAD) in patients with slightly high blood pressure. The study compared aliskiren to a placebo, with both groups also receiving standard heart disease treatments. Researchers used a special ultrasound to measure changes in the patients’ artery health over two years.